Plasminogen Activator Inhibitor‐1 and Diagnosis of the Metabolic Syndrome in a West African Population

Abstract

MetS prevalence in the West African population we studied was comparable to that of the industrialized West. PAI-1 may serve as a key link between MetS, as currently defined, and the endpoints with which it is associated. Whether this association is generalizable will require follow-up.